Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.The negative spread of 10-year treasury bonds between China and the United States has expanded to more than 250BP, the largest since June 2002.Maotai Group had an exchange discussion with Huawei. Kweichow Moutai official news on December 13th. On December 12th, Zhang Pingan, managing director of Huawei Technologies Co., Ltd. and CEO of Huawei Cloud, visited Maotai and held an exchange discussion with Zhang Deqin, Party Secretary and Chairman of Maotai Group.
The three major stock indexes opened lower and went lower. The Shenzhen Stock Exchange Index and the Growth Enterprise Market Index all fell more than 1%, and the Shanghai Composite Index fell 0.88%.Hailian Jinhui invested 20 million yuan to set up an auto parts company in Wuhu. According to the enterprise search APP, Wuhu Hailian Jinhui Auto Parts Co., Ltd. was established recently, with the legal representative of Wang Weichao and the registered capital of 20 million yuan. Its business scope includes: manufacturing of auto parts and accessories; Mold manufacturing; Sales of metal materials; New material technology research and development, etc. Enterprise investigation shows that the company is indirectly wholly-owned by Hailian Jinhui.The Shenzhen Stock Exchange terminated the audit of four bond projects with a total amount of 5.879 billion yuan. On December 13, the Shenzhen Stock Exchange recently terminated the audit of four bond projects with a total amount of 5.879 billion yuan, and the varieties were small public offerings and private placements.
Trump said that he will meet with Amazon founder Bezos next week. US President-elect Trump said on Thursday that he will meet with Amazon founder Bezos next week and stressed that he will continue to contact with technology giants before returning to the White House, including those companies that have signed contracts with the US government. Trump pointed out that he had met with Meta CEO Zuckerberg earlier and had extensive contact with Tesla CEO Musk.Musk moved SpaceX headquarters to the Starbase in Texas.The central parity of RMB against the US dollar was reported at 7.1876, down by 22 points; The median price of the previous trading day was 7.1854, the official closing price of the previous trading day was 7.2630, and it closed at 7.2700 last night.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14